Sep. 10 at 12:05 PM
$NKTR Nektar Therapeutics shares spiked after eczema drug rezpegaldesleukin showed 61% vs. 31% placebo in Phase 2. Data will be presented at EADV 2025. Insiders promptly sold shares, which tends to say more than the slides at conferences.
#ETSY Etsy’s platform engagement & merchant growth are reinforcing the
$72 level. Consumer-spending resilience (whimsigoth, fetish fashion, nostalgia, handmade crafts, domestic charm, heritage demand).
#SG Sweetgreen’s luxury athleisure lifestyle setting: bright & clean interior, crisp greens, bright wooden textures (post-class vibe) is reinforcing the
$18 level. Where energized femininity resonates.
#XHB Homebuilder demand trends & housing supply dynamics are reinforcing the
$120 level. Fed rate-cut speculation & “golden cross” approaching.
#BTC Bitcoin’s on-chain metrics & institutional flows are propping up the
$112,000 level. Fed rate-cut speculation & “liquidity expansion.”
